Related Experiment Video
Updated: Oct 5, 2025
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Developmental Hemostasis: The Evolution of our Coagulation System
Gianna M Guzzardo1, Katherine Regling1,2
1Department of Pediatric Hematology Oncology, Children's Hospital of Michigan, Detroit, MI.
Insights
Neonatal hemostasis differs significantly from adult coagulation, with lower factor levels and unique reference ranges. Understanding these developmental changes is crucial for diagnosing and treating bleeding or clotting disorders in infants.
Area of Science:
- Hematology
- Pediatrics
- Coagulation Science
Background:
- Neonates exhibit distinct coagulation profiles compared to adults, characterized by lower coagulation factor levels and higher screening test results.
- Factors such as gestational age, labor, and clinical condition can influence neonatal hemostasis.
- Interpreting standard coagulation screening tests (prothrombin time, partial thromboplastin time, fibrinogen) in neonates is challenging due to age-specific laboratory reference ranges.
Purpose of the Study:
- To elucidate the concept of developmental hemostasis, outlining the coagulation system's maturation from infancy to adulthood.
- To highlight the importance of understanding neonatal hemostasis for accurate clinical evaluation and management.
- To provide an overview of diagnostic and therapeutic considerations in pediatric coagulation.
Main Methods:
- Review of existing literature on neonatal and pediatric coagulation.
- Analysis of common coagulation screening tests and their interpretation in different age groups.
- Discussion of clinical implications and management strategies for hemostatic disorders in neonates.
Main Results:
- Neonates possess a unique hemostatic system with lower coagulation factor levels and altered screening test results.
- Age-specific reference ranges are essential for interpreting coagulation tests in neonates.
- Developmental hemostasis impacts the diagnosis and treatment of conditions like vitamin K deficiency, surgical bleeding, infections, and inherited thrombotic or bleeding disorders.
Conclusions:
- A comprehensive understanding of developmental hemostasis is critical for effective pediatric hematology practice.
- Accurate interpretation of coagulation tests requires consideration of age-specific norms.
- Appropriate management of neonatal bleeding (platelets, fresh frozen plasma) and thrombosis (heparinoids) is guided by developmental hemostatic principles.
Abstract:
Developmental hemostasis describes the evolution of the coagulation system from the neonatal period through adulthood. Neonates have lower levels of coagulation factors and elevated screening levels at birth. These levels can be influenced by various circumstances including gestational age, labor effects, and clinical status. The most commonly used screening tests for coagulopathy are the prothrombin time, partial thromboplastin time, and fibrinogen level. These values can be difficult to interpret as every laboratory has its own age-specific reference ranges. An understanding of developmental hemostasis is important when evaluating, diagnosing, and treating clinical manifestations, including vitamin K deficiency, surgical needs, infections, inherited thrombophilias, and inherited bleeding disorders. The mainstay of treatment for bleeding or hemorrhage is platelet and fresh frozen plasma transfusions. For the treatment of thrombosis, unfractionated heparin and low-molecular-weight heparin are the 2 most commonly used anticoagulants in the neonatal setting.
More Related Videos
09:12Author Spotlight: Studying hiPSC-Derived Endothelial Cells Cultured Under Fluidic-Mediated Mechanical Stimulation
Published on: July 28, 2023
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
01:05Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
01:09Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:20Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...